| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Published online before print May 24, 2007
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of Neuropathology,
* Experimental Hematology and Transfusion Medicine,
Neurosurgery,
and Pathology,
|| University of Bonn, Bonn; the Max-Planck-Institut für Informatik,
Saarbrücken; and the Department of Neuropathology,
¶ University Düsseldorf, Düsseldorf, Germany
Resistance to chemotherapy is a major complication during treatment of cancer patients. Hypermethylation of the MGMT gene alters DNA repair and is associated with longer survival of glioblastoma patients treated with alkylating agents. Therefore, MGMT promoter methylation plays an important role as a predictive biomarker for chemotherapy resistance. To adopt this established correlation into a molecular diagnosis procedure, we compared and optimized three experimental techniques [combined bisulfite restriction analysis, a primer extension- and denaturing high-performance liquid chromatography-based method named SIRPH (SNuPE ion pair-reverse phase high-performance liquid chromatography), and pyrosequencing] with regard to their accuracy of detecting MGMT promoter methylation. Initially, bisulfite sequencing was used to obtain a comprehensive methylation profile of the MGMT promoter region in 22 glioblastoma samples and in three normal brain controls. Next, we statistically identified CpG sites that best discriminate between methylated and unmethylated MGMT promoters. These results were then used to design optimal combined bisulfite restriction analysis, SIRPH, and pyrosequencing assays for accurate and cost-efficient assessment of MGMT promoter methylation. We compared all three techniques with regard to their reliability and reproducibility on well-characterized tumor samples. The optimized pyrosequencing assay performed best and provides a sensitive, robust, and easy-to-use method for quantitative assessment of MGMT methylation, for both snap-frozen and paraffin-embedded specimens.
This article has been cited by other articles:
 |
|
 |
|
  M. J. van den Bent, H. J. Dubbink, M. Sanson, C. R. van der Lee-Haarloo, M. Hegi, J. W.M. Jeuken, A. Ibdaih, A. A. Brandes, M. J.B. Taphoorn, M. Frenay, et al. MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951 J. Clin. Oncol., December 10, 2009; 27(35): 5881 - 5886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Kristensen and L. L. Hansen PCR-Based Methods for Detecting Single-Locus DNA Methylation Biomarkers in Cancer Diagnostics, Prognostics, and Response to Treatment Clin. Chem., August 1, 2009; 55(8): 1471 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Desaulniers, G.-h. Xiao, H. Lian, Y.-L. Feng, J. Zhu, J. Nakai, and W. J. Bowers Effects of Mixtures of Polychlorinated Biphenyls, Methylmercury, and Organochlorine Pesticides on Hepatic DNA Methylation in Prepubertal Female Sprague-Dawley Rats International Journal of Toxicology, July 1, 2009; 28(4): 294 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Sepulveda, D. Jones, S. Ogino, W. Samowitz, M. L. Gulley, R. Edwards, V. Levenson, V. M. Pratt, B. Yang, K. Nafa, et al. CpG Methylation Analysis--Current Status of Clinical Assays and Potential Applications in Molecular Diagnostics: A Report of the Association for Molecular Pathology J. Mol. Diagn., July 1, 2009; 11(4): 266 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Iafrate and D. N. Louis "MGMT for pt mgmt": Is Methylguanine-DNA Methyltransferase Testing Ready for Patient Management? J. Mol. Diagn., July 1, 2008; 10(4): 308 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bock, J. Walter, M. Paulsen, and T. Lengauer Inter-individual variation of DNA methylation and its implications for large-scale epigenome mapping Nucleic Acids Res., June 1, 2008; 36(10): e55 - e55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Kristensen, T. Mikeska, M. Krypuy, and A. Dobrovic Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection Nucleic Acids Res., April 1, 2008; 36(7): e42 - e42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bock and T. Lengauer Computational epigenetics Bioinformatics, January 1, 2008; 24(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
